America’s top infectious disease expert has rowed back from a suggestion that the U.K. approved a COVID-19 vaccine too quickly.
Dr. Anthony Fauci, the director of the US National Institute of Allergy and Infectious Diseases, claimed American regulators “would do a more thorough job” of assessing the vaccine developed by Pfizer/BioNTech.
Advertisement
He told CBS News that Britain “kind of ran around the corner of the marathon and joined it in the last mile,” adding: “They really rushed through that approval.”
Fauci said: “The FDA, the United States of America Food and Drug Administration, is the gold standard of regulation. They are doing it in a careful way, appropriately.”
He warned that the speed at which the U.K. has approved the Pfizer vaccine could undermine confidence in the shot, telling Sky News: “When we did a survey here in the U.S., there was a considerable degree of skepticism and reluctance to get vaccinated and we were concerned that if we did anything that looked like it was cutting corners that would feed into the scepticism.”
But in a later interview with BBC News, Fauci said he did not mean to “imply any sloppiness,” adding: “I do have great faith in both the scientific community and the regulatory community at the U.K.”
Advertisement
He said there was “no judgement on the way the U.K. did it.”
Fauci told the BBC: “Our process is one that takes more time than it takes in the UK. And that’s just the reality. I did not mean to imply any sloppiness even though it came out that way.”
The comments came as the coronavirus death toll in the U.K. passed the 60,000 mark, jumping to 60,113 on Thursday.
The World Health Organization (WHO) offered a toned-down response to the Medicines and Healthcare products Regulatory Agency’s (MHRA) decision, simply stating the approval had been “acknowledged.”
In response to the comments, the MHRA said in a statement: “We have rigorously assessed the data in the shortest time possible, without compromising the thoroughness of our review.
Advertisement
“COVID-19 vaccines, including this one, are being developed in a co-ordinated in a way that allows some stages of this process to happen in parallel to condense the time needed, but it does not mean steps and the expected standards of safety, quality and effectiveness have been bypassed.”
It added that a rolling review of the vaccine data started at the beginning of October, and since then the data, and had made good progress on the review before the last submission of data was received.
“Any vaccine must undergo robust clinical trials in line with international standards, with oversight provided by the Medicines and Healthcare products Regulatory Agency.
“No vaccine would be authorized for supply in the U.K. unless the expected standards of safety, quality and efficacy are met,” the statement concluded.
Dr. Siddhartha Sankar Datta, WHO regional adviser for vaccine-preventable diseases and immunization in Europe, said: “The national regulatory authority of a country will review the different elements of a system before they make the vaccine licensed for use – (based on) the safety, efficacy and quality of the vaccine.
Advertisement
“That is what the U.K.’s national regulatory authority has done yesterday with their evaluation. We have learned about it and we acknowledge it.”
Despite this criticism, a Cabinet minister declared the U.K. is getting a coronavirus vaccine first because it is a “much better country” than France, Belgium and the U.S.
Education secretary Gavin Williamson praised the work done by the medical regulator to approve the Pfizer/BioNTech vaccine for use.
The first doses of the vaccine are now believed to have arrived in the U.K.
The UK has ordered 40 million doses of the Pfizer jab, enough to vaccinate 20 million people, with 800,000 doses expected to arrive by next week.
Our 2024 Coverage Needs You
It's Another Trump-Biden Showdown — And We Need Your Help
The Future Of Democracy Is At Stake
Our 2024 Coverage Needs You
Your Loyalty Means The World To Us
As Americans head to the polls in 2024, the very future of our country is at stake. At HuffPost, we believe that a free press is critical to creating well-informed voters. That's why our journalism is free for everyone, even though other newsrooms retreat behind expensive paywalls.
Our journalists will continue to cover the twists and turns during this historic presidential election. With your help, we'll bring you hard-hitting investigations, well-researched analysis and timely takes you can't find elsewhere. Reporting in this current political climate is a responsibility we do not take lightly, and we thank you for your support.
The 2024 election is heating up, and women's rights, health care, voting rights, and the very future of democracy are all at stake. Donald Trump will face Joe Biden in the most consequential vote of our time. And HuffPost will be there, covering every twist and turn. America's future hangs in the balance. Would you consider contributing to support our journalism and keep it free for all during this critical season?
HuffPost believes news should be accessible to everyone, regardless of their ability to pay for it. We rely on readers like you to help fund our work. Any contribution you can make — even as little as $2 — goes directly toward supporting the impactful journalism that we will continue to produce this year. Thank you for being part of our story.
It's official: Donald Trump will face Joe Biden this fall in the presidential election. As we face the most consequential presidential election of our time, HuffPost is committed to bringing you up-to-date, accurate news about the 2024 race. While other outlets have retreated behind paywalls, you can trust our news will stay free.
But we can't do it without your help. Reader funding is one of the key ways we support our newsroom. Would you consider making a donation to help fund our news during this critical time? Your contributions are vital to supporting a free press.
As Americans head to the polls in 2024, the very future of our country is at stake. At HuffPost, we believe that a free press is critical to creating well-informed voters. That's why our journalism is free for everyone, even though other newsrooms retreat behind expensive paywalls.
Our journalists will continue to cover the twists and turns during this historic presidential election. With your help, we'll bring you hard-hitting investigations, well-researched analysis and timely takes you can't find elsewhere. Reporting in this current political climate is a responsibility we do not take lightly, and we thank you for your support.
Thank you for your past contribution to HuffPost. We are sincerely grateful for readers like you who help us ensure that we can keep our journalism free for everyone.
The stakes are high this year, and our 2024 coverage could use continued support. Would you consider becoming a regular HuffPost contributor?
Dear HuffPost Reader
Thank you for your past contribution to HuffPost. We are sincerely grateful for readers like you who help us ensure that we can keep our journalism free for everyone.
The stakes are high this year, and our 2024 coverage could use continued support. If circumstances have changed since you last contributed, we hope you'll consider contributing to HuffPost once more.